Should UnBranded Disease Awareness Ads Mention Treatment Risks?

False and misleading drug ads can harm con-sumers and the healthcare system. In order to limit the harm from false Rx drug advertising, FDA’s Office of Prescription Drug Promotion (OPDP) tracks several kinds of regulatory violations such as:Risk omission or minimization Superiority claims Overstatement of efficacy Unsubstantiated claim Broadening of indication Promotion of an unapproved use Promotion of an unapproved compoundAccording EyeforPharma, which has compiled data from FDA Warning and Notice of Violation Letters since 2004, "omission" or "minimization" of risk information is by far the most commonly-cited violation (see chart).This applies to FDA-regulated branded pharma ads, but what about unbranded "disease awareness" ads, which are NOT regulated by the FDA* (see P.P.S.)? When these ads mention the benefits of "drug treatments," should they also mention risks of these treatments and/or life-style changes like branded ads are required to do?Read more »
Source: Pharma Marketing Blog - Category: Pharma Commentators Tags: #Pharma100 ADHD Celebrity Endorsement Disease awareness Regulation Shire Source Type: blogs